Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a0879232fd5d2d792e663c14c267b4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_148e4393503c48409227e5a4d8b4668c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd3f0da90bb72dc6def6b671fc73ba02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59b0f627f9770a0523ad7403842e0863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d01c279fb1d2ae365a1df8af15e5b136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4add7e8af694d8c07c2659fe21e093c5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D489-00 |
filingDate |
2010-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2dc60fba4648efbd007ad31dddb6f95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6303d18029a14caab8205191738f8978 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b6773f1204cd81b6c9510e66c3bd0c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad6df5dbe40028ce2fdf524d275fac11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d19f364b2489733949a08fecdd2c5b38 |
publicationDate |
2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8563724-B2 |
titleOfInvention |
(+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
abstract |
The present invention provides (+)-morphinanium compounds comprising substituted 6-hydroxy or 6-amine groups. The invention also provides methods for inhibiting microglial activation by administering the compounds of the invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9969746-B2 |
priorityDate |
2009-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |